Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.

Projected return on investment in pharma research and development (R&D) in 2024 has risen to 5.9%, continuing the upward ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Perspective Therapeutics (CATX – Research ...

For some Big Pharma companies, sales in China contributed to more than 10 percent of global sales, making China a top market ...

In its annual 'Measuring the Return from Pharmaceutical Innovation' report based on the top 20 pharma companies by 2020 R&D ...

Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

Kneat's SaaS model automates validation processes in pharma and biotech, reducing errors and ensuring compliance. Learn why ...

Eli Lilly and Company, AbbVie, Merck & Co., Inc., Pfizer, D-Wave Quantum, Johnson & Johnson, and Amgen are the seven ...

Some drugmakers are taking the unusual step of sending more medicines by air to the U.S., two executives and two logistics ...

Plus, hear from industry trailblazers representing top 20 pharmaceutical companies in the USA, sharing their expertise on omnichannel strategy, AI-driven engagement, and commercial transformation.

WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on ...